What is CVE-2023-38958?

CVE-2023-38958 is a medium-severity vulnerability in Zkteco Bioaccess Ivs, classified under Incorrect Authorization. CVSS score: 5.3/10. Published 2023-08-03.

How severe is CVE-2023-38958?

Medium severity. CVSS v3 base score is 5.3 out of 10.

Auth bypass in Zkteco Bioaccess Ivs

CVE-2023-38958

An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open the doors managed by the platform remotely via sending a crafted web request.

Vulnerability class: Broken Access Control

EPSS: 0.003 (23.6th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 5.3 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N.

Affected products

Zkteco Bioaccess_ivs — versions 3.3.1
N/a — versions n/a

Weakness classification (CWE)

CWE-863 — Incorrect Authorization

References

af854a3a-2127-422b-91ae-364da2661108 (Product)
cve@mitre.org (Third Party Advisory)

Frequently asked questions

What is CVE-2023-38958?: CVE-2023-38958 is a medium-severity vulnerability in Zkteco Bioaccess Ivs, classified under Incorrect Authorization. CVSS score: 5.3/10. Published 2023-08-03.
How severe is CVE-2023-38958?: Medium severity. CVSS v3 base score is 5.3 out of 10.